Tue, Jul 7, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Ackman to pursue Allergan acquisition, a new corporate actions model emerges

Tuesday, April 22, 2014

Bailey McCann, Opalesque New York:

As Opalesque recently reported, investors are lining up for activist strategies. Those investors may be interested in the latest news from Pershing Square CEO Bill Ackman who is teaming up with Valeant Pharmaceuticals International Inc. seek to acquire the botox maker, Allergan Inc. The partnership was first reported late yesterday afternoon and marks another high profile bet for the activist who has recently staked out positions on Herbalife and JC Penny.

Valeant owns other well known brands including Bausch & Lomb and focuses heavily on eye-care. According to reports, Valeant has been trying to acquire Allergan for some time, but this acquisition attempt is likely to be hostile. Both companies posted gains in after hours trading.

The New York Times notes that if the bid is successful, a hedge fund teaming up with a corporation could provide a new model for corporate actions. The deal would have to be approved by regulators which are likely to give the transaction close scrutiny given the possibility for conflicts of interest. ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: New systematic strategy managed alongside research firm outperforms S&P500[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: An emerging CTA manager explains how he runs his strategy, which is based on an index produced by a research firm. Peter Turk is head of

  2. Opalesque Exclusive: New systematic strategy embraces machine learning[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: The founder of a New York-based systematic trading firm, which offers a hybrid between alpha strategies and alternative feta at lower fees, describes his approa

  3. Larry Robbins' hedge fund Glenview buys 1m Tenet Healthcare shares[more]

    Komfie Manalo, Opalesque Asia: Glenview Capital Management said it bought an additional 979,482 shares at Tenet Healthcare Corp valued at $53.80 million, raising its stakes in the healthcare services company to 15.16%, reported

  4. Legal - Grayson’s hedge funds under scrutiny for possible ethics violations, Court rejects hedge fund’s motion to block merger of Samsung affiliates[more]

    Grayson’s hedge funds under scrutiny for possible ethics violations From Freebeacon.com: Rep. Alan Grayson is finding himself in hot water over managing hedge funds that bear his name, actions that are in possible violation of House ethics rules. Sitting members of Congress are prohibite

  5. Hedge funds decline in June as stocks tumble on Greek woes[more]

    From Bloomberg.com: Hedge funds posted losses across strategies last month as uncertainty over whether Greece will remain in the euro sent global stock markets tumbling. Winton Capital Management declined about 3.1 percent in June in its $12.1 billion Winton Futures Fund, leaving it down 1.9 percent

 

banner